| Particulars |
|
|
|
| Company Name
| Gland Pharma Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
16.48 |
B.V. (₹) |
556.80 |
| Sales(₹ Cr.) |
4,167.43 |
NP (₹ Cr.) |
1,043.71 |
| NP Var% |
28.00 |
Div% |
2,000.00 |
| CPS(₹) |
73.20 |
EPS (₹) |
63.30 |
| Traded Value(₹ Lakhs) |
69.26 |
52 Week High |
2,221.00 |
| 52 Week Low |
1,200.00 |
Price BSE |
1,450.00 |
| Price NSE |
1,451.00 |
Market Capital (₹ Cr.) |
23,892.98 |
| P/C Ratio |
19.80 |
P/E Ratio |
22.90 |
| Price Vs.BV |
2.60 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
1,010.78 |
| NP(₹ Cr.) |
295.12 |
NP Var % |
7.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
4,347.71 |
| OPM |
33.57 |
NP |
1,102.85 |
| NP Var% |
34.15 |
EPS |
68.05 |
| PE |
21.31 |
|
|